Docus vs Woebot Health

Docus is a health technology platform built for diagnostic labs, doctors, and patients. Its homepage positions the product as an AI layer for modern diagnostic labs, with modules for interpretation reports, follow-up recommendations, compliance checks, digital requisitions, and context-aware assistants.

For labs, Docus turns raw test results into clinical reports for doctors and patient-friendly explanations. It supports routine panels, infectious disease, pharmacogenomics, and pathology workflows. Labs can connect via API or HL7 into an LIS, CRM, or EHR, or use branded Docus interfaces without integration.

Doctors get a clinical decision support platform with an AI medical assistant, research assistant, lab test interpretation, AI-generated SOAP notes, and patient messaging with AI auto-complete. Plans scale by number of patients managed, and the first patient is free.

Patients use the AI Health Assistant to chat with a personal AI Doctor, upload lab results for interpretation, run a symptom checker, and request second opinions from a network of 350+ doctors across 30+ specialties.

Docus states it meets HIPAA, GDPR, and SOC 2 requirements, encrypts data in transit and at rest, and does not require personally identifiable information for core workflows. The company is based in Wilmington, Delaware.

Woebot Health builds chat-based mental healthcare tools for health systems, payers, and employers rather than selling a standalone app on the App Store. Its relational agent delivers scripted conversations written by clinical writers and psychologists, using natural language processing to match user input with techniques like CBT, IPT, and DBT. Patients get 24/7 adjunctive support between clinic visits while clinicians receive patient-reported outcome data without added workload.

The company pivoted away from its direct-to-consumer mobile app in 2025 to license its platform through enterprise contracts. That shift matches how the product actually works: EMR-integrated deployments for Access Accelerator, Population Health, and Medicare Advantage programs, with modules tailored to adults, adolescents, maternal health, and adults 65+. Most population-specific products are wellness adjuncts and are not FDA cleared or approved.

Woebot Health differentiates on clinical rigor over generic chatbot polish. Studies run through IRB review, concerning language triggers referrals to external crisis resources, and the stack carries HIPAA compliance, SOC 2 Type 2 examination, and ORCHA safety ratings. Health organizations evaluating digital mental health vendors who need audit-ready privacy posture and validated PRO scales like PHQ-8 and PHQ-9 are the natural buyers.